معرفی
Michael Chopin is a Senior Research Fellow at Monash University's Biochemistry & Molecular Biology Department, leading research on dendritic cell (DC) transcriptional programming and immune system mechanisms. He obtained his PhD in Immunology from the Max Planck Institute for Molecular Cell Biology and Genetics (2011). His postdoctoral work at the Walter and Eliza Hall Institute (WEHI) focused on DC differentiation and genomic technologies. Since 2022, he has led an independent group investigating DC function in immunity and cancer.
Education:
- PhD in Immunology, Max Planck Institute (2006–2010)
- Postdoctoral Fellowships at WEHI (2011–2022)
Research Interests:
Chopin's work centers on transcriptional control of DC development, innate immune cell interactions, and their role in cancer immunotherapy. His lab employs genomic tools and mouse models to study cell fate decisions and therapeutic applications. Key areas include dendritic cell diversity, cytokine regulation, and tumor microenvironment dynamics.
Awards:
- Emerging Leader (2021)
- Jenny Thatchell/Pauline Speedy Innovation Award (2020)
- Barbara McDonald Innovation Award (2019)
- DC 2016-Chinese Society of Immunology Award (2016)
Grants & Projects:
- Lead Investigator: 'Tailoring dendritic cell diversity to advance effective immunotherapies' (2022–2025)
Labs/Teams: Monash University's DC Signaling & Immunotherapy Group.
